Status:
UNKNOWN
Risk Factors for Severe Disease in Hospitalized Patients With COVID-19 and the Effect of Azvudine Treatment: a Retrospective Cohort Study
Lead Sponsor:
Fifth Affiliated Hospital, Sun Yat-Sen University
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to explore the factors that can affect the development of severe cases in hospitalized patients with COVID-19, including basic diseases, laboratory parameters, and clinica...
Detailed Description
4201 COVID-19 patients discharged from our hospital were enrolled. Binary logistic regression analysis and ROC curve were used to investigate the role of comorbidities, laboratory parameters and clini...
Eligibility Criteria
Inclusion
- The COVID-19 positive patients
Exclusion
- patients treated with both azvudine and monotamivir;
- patients receiving other antiviral drugs such as nematavir/ritonavir;
- age \< 18 years old
Key Trial Info
Start Date :
August 5 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2023
Estimated Enrollment :
4201 Patients enrolled
Trial Details
Trial ID
NCT06006611
Start Date
August 5 2023
End Date
October 30 2023
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Fifth Affiliated Hospital of Sun Yat-sen University
Zhuhai, Guangdong, China, 519000